Because of the life-long implications of FAP for both patients and their immediate relatives, it is currently recommended that all children with HB be screened for APC mutations, although it can be argued that this be reserved for those individuals whose tumors harbor wild-type CTNNB1 genes [32,95]. Here, CTNNB1 is linked to hemoglobin measurement.